NIH Issues Compliance Reminder
on Research Involving Recombinant DNA Molecules
May 31, 2002- The National Institutes of Health (NIH)
May 28 issued a special
notice reminding the research community of the need to
comply with the "NIH Guidelines for Research Involving
Recombinant DNA Molecules" which stipulate biosafety
and containment measures for research involving recombinant
DNA research and delineate additional requirements for human
gene transfer studies.
The notice highlights recent changes to the safety reporting
requirements associated with human gene transfer studies and
the important roles and responsibilities of the Institutional
Biosafety Committee (IBC) in the local review of recombinant
DNA research. NIH also reminded institutions that "privately
funded projects employing recombinant DNA must adhere to the
NIH Guidelines if they are being carried out at, or funded
by, an organization that has any NIH contracts, grants, or
other support for this kind of research."
Information:
Tony Mazzaschi, Senior Associate Vice President
AAMC Biomedical Health Sciences Research
tmazzaschi@aamc.org
(202) 828-0059
Get Washington Highlights
in your Inbox!
| 
